CASSANDRA ARPIN: Open Payments
NPI 1205461480 · AMSTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 4 payments from 4 companies in 2025. Trend: 2023 $17 · 2024 $190 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: INGREZZA, COBENFY, INVEGA SUSTENNA, REXULTI.
Industry payments across CT — which companies pay providers there.
